This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign in
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

Learn about the efficacy and safety of Somavert, its tumour impact and its effect on co-morbidity management through clinical and real world data

The acromegaly disease activity tool designed to help monitor your patients

Advice and support services to help you and your patients optimise your experience with Somavert about the efficacy and safety of Somavert through clinical and real world data

Learn about funding and reimbursement England, Scotland, Wales and Northern Ireland

Watch and listen to acromegaly experts talk about various topics in the disease area as well as recordings from our National Nurse Meeting and the Acromegaly co-morbidity series

Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.


Download Somavert materials

HCP materials
 

Header

This text is for block level content. P tags can go in here too

ACRODAT healthcare professional guide

Header

This text is for block level content. P tags can go in here too

PRIMARY ENDPOINT

  • Success in ISGA

SECONDARY ENDPOINT

  • Time to success in ISGA
  • Clear or almost clear

OTHER ENDPOINTS

  • Pruritus
  • Quality of life assessments

Find information on the development of ACRODAT, adding and evaluating patients and visit data

Download GB VersionDownload NI Version

Card Header

The card body Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam

Card CTA

** This is an optional area where footnotes can live.

Card Header

Lorem ipsum dolor sit amet

Card CTA

Header

This text is for block level content. P tags can go in here too

Somavert healthcare professional prescribing guide

Find information on funding, initiation, homecare and follow-up

Download

Patient materials 

Header

This text is for block level content. P tags can go in here too

VIRNA, the Somavert Virtual Nurse Assistant patient information

Find information for your patients on the Somavert Virtual Nurse Assistant application which uses augmented reality to support patients in the self-administration of Somavert.

Download GB VersionDownload NI Version

Acromegaly and diabetes patient information

Find information for your patients on living with acromegaly and diabetes

Download

Acromegaly and quality of life patient information

Find information for your patients on the impact of acromegaly on well being 

Download
Contact us about our support services 

PP-SOM-GBR-1125. January 2022

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?